Ketokaps Med (Ketoprofen)

Ketoprofen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the synthesis of prostaglandins. Lower prostaglandin levels lead to decreased inflammation, pain signalling, and fever.

The appropriate dose of Ketokaps Med is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions exactly.

Safety of ketoprofen in pregnancy and lactation has not been fully established. It is generally avoided in the third trimester and used only if the potential benefit justifies the risk. Breastfeeding mothers should consult their physician before use.

To request Ketokaps Med, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoprofen has a potency comparable to ibuprofen and naproxen but may offer a longer duration of analgesic effect for some patients. Its safety profile is similar to other non‑selective NSAIDs, with comparable risks of gastrointestinal, renal and cardiovascular adverse events.

Ketokaps Med should be stored at ambient temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Ketokaps Med is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. The exact administration schedule is set by the prescriber.

Serious risks include gastrointestinal bleeding or ulceration, severe renal impairment, hepatic injury, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of bleeding, severe abdominal pain, jaundice, or rash.

Ketokaps Med should be avoided in individuals with known hypersensitivity to ketoprofen or other NSAIDs, those with active gastrointestinal ulcer disease, severe renal or hepatic impairment, and patients in the third trimester of pregnancy. Consultation with a healthcare professional is essential before starting therapy.